Opinion

Video

The Role of PSA Doubling Time in Risk Assessment

Specialists examine non-metastatic castration-sensitive prostate cancer cases, evaluating the significance of PSA doubling time and the reliability of biomarkers in risk assessment for these patients.

Related Videos
5 KOLs are featured in this program
5 KOLs are featured in this program
A panel of 3 experts on CLL
A panel of 3 experts on CLL
Marc-Oliver Grimm, MD
2 KOLs are featured in this program.
2 KOLs are featured in this program.
2 KOLs are featured in this series